Last update 08 May 2025

ThisCART 22(Fundamenta Therapeutics,)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
Allogeneic CAR-T targeting CD22
Target
CD22
Action
inhibitors
Mechanism
CD22 inhibitors(CD22 inhibitors), Gene transference, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
B-cell lymphoma refractoryB-Cell Malignant Neoplasm
Originator Organization
Fundamenta Therapeutics, Ltd.
Active Organization-
Inactive Organization
Fundamenta Therapeutics, Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with ThisCART 22(Fundamenta Therapeutics,)
NCT05106946
/ Unknown statusPhase 1
An Open and Single Dose-escalation Study to Evaluate the Safety and Clinical Activity of Allogeneic CAR-T Targeting CD22(ThisCART22) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma (r/r B-NHL)
NCT04601181
/ Unknown statusPhase 1
A Study to Evaluate the Safety and Clinical Activity of Allogeneic CAR-T Targeting CD22 in Patients With Refractory or Relapsed B Cell Malignancies
100 Clinical Results associated with ThisCART 22(Fundamenta Therapeutics,)
Login to view more data
100 Translational Medicine associated with ThisCART 22(Fundamenta Therapeutics,)
Login to view more data
100 Patents (Medical) associated with ThisCART 22(Fundamenta Therapeutics,)
Login to view more data
100 Deals associated with ThisCART 22(Fundamenta Therapeutics,)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-cell lymphoma refractoryPhase 1
China
Fundamenta Therapeutics, Ltd.
25 Oct 2021
B-Cell Malignant NeoplasmPhase 1
China
Fundamenta Therapeutics, Ltd.
23 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free